Your browser doesn't support javascript.
loading
Retinal vessel changes in pulmonary arterial hypertension.
DuPont, Mariana; Lambert, Savanna; Rodriguez-Martin, Antonio; Hernandez, Okaeri; Lagatuz, Mark; Yilmaz, Taygan; Foderaro, Andrew; Baird, Grayson L; Parsons-Wingerter, Patricia; Lahm, Tim; Grant, Maria B; Ventetuolo, Corey E.
Affiliation
  • DuPont M; Department of Ophthalmology and Visual Sciences University of Alabama at Birmingham Birmingham Alabama USA.
  • Lambert S; School of Public Health University of Alabama Birmingham Birmingham Alabama USA.
  • Rodriguez-Martin A; Department of Clinical & Diagnostic Sciences University of Alabama at Birmingham Birmingham Alabama USA.
  • Hernandez O; Department of Biology University of Alabama at Birmingham Birmingham Alabama USA.
  • Lagatuz M; Redline Performance Solutions, Ames Research Center National Aeronautics and Space Administration Moffett Field California USA.
  • Yilmaz T; Division of Ophthalmology and Department of Surgery Alpert Medical School of Brown University Providence Rhode Island USA.
  • Foderaro A; Division of Pulmonary, Critical Care and Sleep Medicine, Department of Medicine Alpert Medical School of Brown University Providence Rhode Island USA.
  • Baird GL; Department of Diagnostic Imaging, Alpert Medical School of Brown University Rhode Island Hospital Providence Rhode Island USA.
  • Parsons-Wingerter P; Low Gravity Exploration Technology, Research, and Engineering Directorate, John Glenn Research Center National Aeronautics and Space Administration Cleveland Ohio USA.
  • Lahm T; Department of Medicine, Division of Pulmonary Critical Care, Occupational and Sleep Medicine Indiana University Indianapolis Indiana USA.
  • Grant MB; Department of Anatomy, Cell Biology & Physiology Indiana University Indianapolis Indiana USA.
  • Ventetuolo CE; Richard L. Roudebush VA Medical Center Indianapolis Indiana USA.
Pulm Circ ; 12(1): e12035, 2022 Jan.
Article in En | MEDLINE | ID: mdl-35506088
ABSTRACT
Pulmonary arterial hypertension (PAH) is classically considered an isolated small vessel vasculopathy of the lungs with peripheral pulmonary vascular obliteration. Systemic manifestations of PAH are increasingly acknowledged, but data remain limited. We hypothesized that retinal vascular changes occur in PAH. PAH subjects underwent retinal fluorescein angiography (FA) and routine disease severity measures were collected from the medical record. FA studies were analyzed using VESsel GENerational Analysis (VESGEN), a noninvasive, user-interactive computer software that assigns branching generation to large and small vessels. FAs from controls (n = 8) and PAH subjects (n = 9) were compared. The tortuosity of retinal arteries was higher in PAH subjects compared to unmatched controls (1.17, 95% confidence interval [1.14, 1.20] in PAH vs. 1.13, 95% CI [1.12, 1.14] in controls, p = 0.01). Venous tortuosity was higher and more variable in PAH (1.17, 95% CI [1.14, 1.20]) compared to controls (1.13, 95% CI [1.12, 1.15]), p = 0.02. PAH subjects without connective tissue disease had the highest degree of retinal tortuosity relative to controls (arterial, p = 0.01; venous, p = 0.03). Younger PAH subjects had greater retinal arterial tortuosity, which attenuated with age and was not observed in controls. Retinal vascular parameters correlated with some clinical measures of disease in PAH subjects. In conclusion, PAH subjects exhibit higher retinal vascular tortuosity. Retinal vascular changes may track with pulmonary vascular disease progression. Use of FA and VESGEN may facilitate early, noninvasive detection of PAH.
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Pulm Circ Year: 2022 Type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Pulm Circ Year: 2022 Type: Article